Literature DB >> 28708421

Relationship between Race and the Effect of Fluids on Long-term Mortality after Acute Respiratory Distress Syndrome. Secondary Analysis of the National Heart, Lung, and Blood Institute Fluid and Catheter Treatment Trial.

Sarah E Jolley1, Catherine L Hough2, Gilles Clermont3, Douglas Hayden4, Suqin Hou4, David Schoenfeld4, Nicholas L Smith5, Boyd Taylor Thompson6, Gordon R Bernard7, Derek C Angus3.   

Abstract

RATIONALE: Short-term follow-up in the Fluid and Catheter Treatment Trial (FACTT) suggested differential mortality by race with conservative fluid management, but no significant interaction.
OBJECTIVE: In a post hoc analysis of FACTT including 1-year follow-up, we sought to estimate long-term mortality by race and test for an interaction between fluids and race.
METHODS: We performed a post hoc analysis of FACTT and the Economic Analysis of Pulmonary Artery Catheters (EAPAC) study (which included 655 of the 1,000 FACTT patients with near-complete 1-year follow up). We fit a multistate Markov model to estimate 1-year mortality for all non-Hispanic black and white randomized FACTT subjects. The model estimated the distribution of time from randomization to hospital discharge or hospital death (available on all patients) and estimated the distribution of time from hospital discharge to death using data on patients after hospital discharge for patients in EAPAC. The 1-year mortality was found by combining these estimates.
RESULTS: Non-Hispanic black (n = 217, 25%) or white identified subjects (n = 641, 75%) were included. There was a significant interaction between race and fluid treatment (P = 0.012). One-year mortality was lower for black subjects assigned to conservative fluids (38 vs. 54%; mean mortality difference, 16%; 95% confidence interval, 2-30%; P = 0.027 between conservative and liberal). Conversely, 1-year mortality for white subjects was 35% versus 30% for conservative versus liberal arms (mean mortality difference, -4.8%; 95% confidence interval, -13% to 3%; P = 0.23).
CONCLUSIONS: In our cohort, conservative fluid management may have improved 1-year mortality for non-Hispanic black patients with ARDS. However, we found no long-term benefit of conservative fluid management in white subjects.

Entities:  

Mesh:

Year:  2017        PMID: 28708421      PMCID: PMC5711400          DOI: 10.1513/AnnalsATS.201611-906OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  23 in total

1.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

2.  Functional trajectories among older persons before and after critical illness.

Authors:  Lauren E Ferrante; Margaret A Pisani; Terrence E Murphy; Evelyne A Gahbauer; Linda S Leo-Summers; Thomas M Gill
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

Review 3.  Syndemics and the biosocial conception of health.

Authors:  Merrill Singer; Nicola Bulled; Bayla Ostrach; Emily Mendenhall
Journal:  Lancet       Date:  2017-03-04       Impact factor: 79.321

4.  The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury.

Authors:  Kirsten Neudoerffer Kangelaris; Anil Sapru; Carolyn S Calfee; Kathleen D Liu; Ludmila Pawlikowska; John S Witte; Eric Vittinghoff; Hanjing Zhuo; Andrew D Auerbach; Elad Ziv; Michael A Matthay
Journal:  Chest       Date:  2011-12-29       Impact factor: 9.410

5.  Differential distribution of allelic variants in cytokine genes among African Americans and White Americans.

Authors:  Roberta B Ness; Catherine L Haggerty; Gail Harger; Robert Ferrell
Journal:  Am J Epidemiol       Date:  2004-12-01       Impact factor: 4.897

6.  Impact of Initial Central Venous Pressure on Outcomes of Conservative Versus Liberal Fluid Management in Acute Respiratory Distress Syndrome.

Authors:  Matthew W Semler; Arthur P Wheeler; B Taylor Thompson; Gordon R Bernard; Herbert P Wiedemann; Todd W Rice
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

7.  African-American and white patients admitted to the intensive care unit: is there a difference in therapy and outcome?

Authors:  J F Williams; J E Zimmerman; D P Wagner; M Hawkins; W A Knaus
Journal:  Crit Care Med       Date:  1995-04       Impact factor: 7.598

8.  Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials.

Authors:  Niall D Ferguson; Damon C Scales; Ruxandra Pinto; M Elizabeth Wilcox; Deborah J Cook; Gordon H Guyatt; Holger J Schünemann; John C Marshall; Margaret S Herridge; Maureen O Meade
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

Review 9.  Co-occurring epidemics, syndemics, and population health.

Authors:  Alexander C Tsai; Emily Mendenhall; James A Trostle; Ichiro Kawachi
Journal:  Lancet       Date:  2017-03-04       Impact factor: 79.321

10.  The effect of pulmonary artery catheter use on costs and long-term outcomes of acute lung injury.

Authors:  Gilles Clermont; Lan Kong; Lisa A Weissfeld; Judith R Lave; Gordon D Rubenfeld; Mark S Roberts; Alfred F Connors; Gordon R Bernard; B Taylor Thompson; Arthur P Wheeler; Derek C Angus
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

View more
  7 in total

1.  Fluid Management in Acute Respiratory Distress Syndrome: Do We Have All the FACTTs to Determine the Effect of Race?

Authors:  Lucian T Marts; Jordan A Kempker; Greg S Martin
Journal:  Ann Am Thorac Soc       Date:  2017-09

Review 2.  Fluid Management in Acute Respiratory Distress Syndrome.

Authors:  Jonathan D Casey; Matthew W Semler; Todd W Rice
Journal:  Semin Respir Crit Care Med       Date:  2019-05-06       Impact factor: 3.119

Review 3.  Immunomodulatory roles of red blood cells.

Authors:  Jane Dobkin; Nilam S Mangalmurti
Journal:  Curr Opin Hematol       Date:  2022-07-18       Impact factor: 3.218

4.  Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients - insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis.

Authors:  Sanchit Ahuja; Harm-Jan de Grooth; Frederique Paulus; Fleur L van der Ven; Ary Serpa Neto; Marcus J Schultz; Pieter R Tuinman
Journal:  Crit Care       Date:  2022-06-01       Impact factor: 19.334

5.  African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Shashi K Bellam; Jonathan H Chung; Paul A Chung; Kathleen M Biblowitz; Steven Montner; Cathryn Lee; Scully Hsu; Aliya N Husain; Rekha Vij; Gokhan Mutlu; Imre Noth; Matthew M Churpek; Mary E Strek
Journal:  Eur Respir J       Date:  2018-06-14       Impact factor: 16.671

Review 6.  Fluid administration and monitoring in ARDS: which management?

Authors:  Philippe Vignon; Bruno Evrard; Pierre Asfar; Mattia Busana; Carolyn S Calfee; Silvia Coppola; Julien Demiselle; Guillaume Geri; Mathieu Jozwiak; Greg S Martin; Luciano Gattinoni; Davide Chiumello
Journal:  Intensive Care Med       Date:  2020-11-09       Impact factor: 17.440

Review 7.  Fluids in ARDS: more pros than cons.

Authors:  Renata de S Mendes; Paolo Pelosi; Marcus J Schultz; Patricia R M Rocco; Pedro L Silva
Journal:  Intensive Care Med Exp       Date:  2020-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.